0 XP   0   0   0

Adynxx Inc
Buy, Hold or Sell?

Should you buy, hold or sell Adynxx?

I guess you are interested in Adynxx Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Adynxx

Let's start. I'm going to help you getting a better view of Adynxx Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Adynxx Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Adynxx Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Adynxx Inc. The closing price on 2023-03-20 was $0.0003 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Adynxx Inc Daily Candlestick Chart
Adynxx Inc Daily Candlestick Chart
Summary









1. Valuation of Adynxx




Current price per share

$0.00

2. Growth of Adynxx




Is Adynxx growing?

Current yearPrevious yearGrowGrow %
How rich?$8.2m$15.6m-$7.4m-89.9%

How much money is Adynxx making?

Current yearPrevious yearGrowGrow %
Making money-$8.4m-$25.7m$17.2m?
Net Profit Margin-379.8%-131.4%--

How much money comes from the company's main activities?

3. Financial Health of Adynxx




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Adynxx Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Adynxx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Adynxx to the Biotechnology industry mean.
  • A Net Profit Margin of -379.8% means that $-3.80 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Adynxx Inc:

  • The MRQ is -379.8%. The company is making a huge loss. -2
  • The TTM is -379.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-379.8%TTM-379.8%0.0%
TTM-379.8%YOY-131.4%-248.4%
TTM-379.8%5Y-222.0%-157.8%
5Y-222.0%10Y-222.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-379.8%-263.8%-116.0%
TTM-379.8%-331.2%-48.6%
YOY-131.4%-347.0%+215.6%
5Y-222.0%-563.8%+341.8%
10Y-222.0%-671.7%+449.7%
1.1.2. Return on Assets

Shows how efficient Adynxx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Adynxx to the Biotechnology industry mean.
  • -87.0% Return on Assets means that Adynxx generated $-0.87 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Adynxx Inc:

  • The MRQ is -87.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -87.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-87.0%TTM-87.0%0.0%
TTM-87.0%YOY-78.0%-8.9%
TTM-87.0%5Y-72.3%-14.7%
5Y-72.3%10Y-72.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-87.0%-12.4%-74.6%
TTM-87.0%-12.2%-74.8%
YOY-78.0%-11.4%-66.6%
5Y-72.3%-15.2%-57.1%
10Y-72.3%-17.5%-54.8%
1.1.3. Return on Equity

Shows how efficient Adynxx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Adynxx to the Biotechnology industry mean.
  • -102.0% Return on Equity means Adynxx generated $-1.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Adynxx Inc:

  • The MRQ is -102.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -102.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-102.0%TTM-102.0%0.0%
TTM-102.0%YOY-164.1%+62.1%
TTM-102.0%5Y-118.0%+16.0%
5Y-118.0%10Y-118.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-102.0%-15.1%-86.9%
TTM-102.0%-16.0%-86.0%
YOY-164.1%-13.3%-150.8%
5Y-118.0%-19.5%-98.5%
10Y-118.0%-20.6%-97.4%

1.2. Operating Efficiency of Adynxx Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Adynxx is operating .

  • Measures how much profit Adynxx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Adynxx to the Biotechnology industry mean.
  • An Operating Margin of -231.0% means the company generated $-2.31  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Adynxx Inc:

  • The MRQ is -231.0%. The company is operating very inefficient. -2
  • The TTM is -231.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-231.0%TTM-231.0%0.0%
TTM-231.0%YOY-56.5%-174.5%
TTM-231.0%5Y-107.2%-123.8%
5Y-107.2%10Y-107.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-231.0%-261.8%+30.8%
TTM-231.0%-322.4%+91.4%
YOY-56.5%-359.4%+302.9%
5Y-107.2%-550.9%+443.7%
10Y-107.2%-663.1%+555.9%
1.2.2. Operating Ratio

Measures how efficient Adynxx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.17 means that the operating costs are $4.17 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Adynxx Inc:

  • The MRQ is 4.166. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.166. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.166TTM4.1660.000
TTM4.166YOY2.175+1.991
TTM4.1665Y3.051+1.115
5Y3.05110Y3.0510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1663.629+0.537
TTM4.1664.113+0.053
YOY2.1754.933-2.758
5Y3.0517.271-4.220
10Y3.0518.489-5.438

1.3. Liquidity of Adynxx Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Adynxx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.20 means the company has $0.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Adynxx Inc:

  • The MRQ is 0.202. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.202. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.202TTM0.2020.000
TTM0.202YOY1.214-1.012
TTM0.2025Y4.280-4.078
5Y4.28010Y4.2800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2024.895-4.693
TTM0.2025.355-5.153
YOY1.2146.155-4.941
5Y4.2806.378-2.098
10Y4.2806.501-2.221
1.3.2. Quick Ratio

Measures if Adynxx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Adynxx to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Adynxx Inc:

  • The MRQ is 0.004. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.004. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.004TTM0.0040.000
TTM0.004YOY-+0.004
TTM0.0045Y0.001+0.002
5Y0.00110Y0.0010.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0044.343-4.339
TTM0.0044.995-4.991
YOY-5.719-5.719
5Y0.0015.885-5.884
10Y0.0015.854-5.853

1.4. Solvency of Adynxx Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Adynxx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Adynxx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.15 means that Adynxx assets are financed with 14.7% credit (debt) and the remaining percentage (100% - 14.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Adynxx Inc:

  • The MRQ is 0.147. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.147. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.147TTM0.1470.000
TTM0.147YOY0.524-0.377
TTM0.1475Y0.361-0.214
5Y0.36110Y0.3610.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1470.286-0.139
TTM0.1470.279-0.132
YOY0.5240.282+0.242
5Y0.3610.375-0.014
10Y0.3610.413-0.052
1.4.2. Debt to Equity Ratio

Measures if Adynxx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Adynxx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 17.3% means that company has $0.17 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Adynxx Inc:

  • The MRQ is 0.173. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.173. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.173TTM0.1730.000
TTM0.173YOY1.103-0.930
TTM0.1735Y0.658-0.485
5Y0.65810Y0.6580.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1730.326-0.153
TTM0.1730.338-0.165
YOY1.1030.275+0.828
5Y0.6580.418+0.240
10Y0.6580.453+0.205

2. Market Valuation of Adynxx Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Adynxx generates.

  • Above 15 is considered overpriced but always compare Adynxx to the Biotechnology industry mean.
  • A PE ratio of -1.81 means the investor is paying $-1.81 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Adynxx Inc:

  • The EOD is 0.000. Company is losing money. -2
  • The MRQ is -1.815. Company is losing money. -2
  • The TTM is -1.815. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-1.815+1.814
MRQ-1.815TTM-1.8150.000
TTM-1.815YOY-0.909-0.905
TTM-1.8155Y-1.077-0.737
5Y-1.07710Y-1.0770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-6.110+6.110
MRQ-1.815-7.768+5.953
TTM-1.815-10.536+8.721
YOY-0.909-22.222+21.313
5Y-1.077-17.760+16.683
10Y-1.077-18.130+17.053
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Adynxx.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Adynxx Inc:

  • The MRQ is -1.224. Very Bad. -2
  • The TTM is -1.224. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-1.224TTM-1.2240.000
TTM-1.224YOY-3.177+1.953
TTM-1.2245Y-2.201+0.976
5Y-2.20110Y-2.2010.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.224-6.089+4.865
TTM-1.224-8.339+7.115
YOY-3.177-16.232+13.055
5Y-2.201-14.733+12.532
10Y-2.201-13.971+11.770

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Adynxx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.32 means the investor is paying $1.32 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Adynxx Inc:

  • The EOD is 0.000. Very good. +2
  • The MRQ is 1.316. Good. +1
  • The TTM is 1.316. Good. +1
Trends
Current periodCompared to+/- 
EOD0.000MRQ1.316-1.316
MRQ1.316TTM1.3160.000
TTM1.316YOY0.671+0.645
TTM1.3165Y0.698+0.618
5Y0.69810Y0.6980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0001.748-1.748
MRQ1.3162.116-0.800
TTM1.3162.679-1.363
YOY0.6714.107-3.436
5Y0.6983.685-2.987
10Y0.6983.821-3.123
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Adynxx Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.277-1.2770%-2.828+121%0.474-370%0.474-370%
Book Value Growth--0.5270.5270%0.488+8%0.507+4%0.507+4%
Book Value Per Share--1.4211.4210%2.698-47%3.215-56%3.215-56%
Book Value Per Share Growth--0.5270.5270%0.488+8%0.507+4%0.507+4%
Current Ratio--0.2020.2020%1.214-83%4.280-95%4.280-95%
Debt To Asset Ratio--0.1470.1470%0.524-72%0.361-59%0.361-59%
Debt To Equity Ratio--0.1730.1730%1.103-84%0.658-74%0.658-74%
Dividend Per Share----0%-0%-0%-0%
Eps---1.030-1.0300%-1.991+93%-1.394+35%-1.394+35%
Eps Growth--1.4821.4820%0.286+418%0.884+68%0.884+68%
Free Cash Flow Per Share---1.672-1.6720%-1.868+12%-1.598-4%-1.598-4%
Free Cash Flow Per Share Growth--1.1051.1050%0.511+116%0.808+37%0.808+37%
Free Cash Flow To Equity Per Share---1.050-1.0500%-1.878+79%-0.377-64%-0.377-64%
Free Cash Flow To Equity Per Share Growth--1.4411.4410%-1.045+173%0.198+628%0.198+628%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---3.798-3.7980%-1.314-65%-2.220-42%-2.220-42%
Operating Margin---2.310-2.3100%-0.565-76%-1.072-54%-1.072-54%
Operating Ratio--4.1664.1660%2.175+92%3.051+37%3.051+37%
Pb Ratio0.000-623233%1.3161.3160%0.671+96%0.698+89%0.698+89%
Pe Ratio0.000+100%-1.815-1.8150%-0.909-50%-1.077-41%-1.077-41%
Peg Ratio---1.224-1.2240%-3.177+160%-2.201+80%-2.201+80%
Price Per Share0.000-623233%1.8701.8700%1.810+3%1.423+31%1.423+31%
Price To Total Gains Ratio0.000+100%-1.465-1.4650%-0.640-56%-0.666-55%-0.666-55%
Profit Growth--1.6731.6730%1.090+53%1.381+21%1.381+21%
Quick Ratio--0.0040.0040%-+100%0.001+200%0.001+200%
Return On Assets---0.870-0.8700%-0.780-10%-0.723-17%-0.723-17%
Return On Equity---1.020-1.0200%-1.641+61%-1.180+16%-1.180+16%
Revenue Growth--0.1130.1130%1.073-89%0.593-81%0.593-81%
Total Gains Per Share---1.277-1.2770%-2.828+121%0.474-370%0.474-370%
Total Gains Per Share Growth--1.5481.5480%-0.512+133%0.518+199%0.518+199%
Usd Book Value--8252000.0008252000.0000%15667000.000-47%18669666.667-56%18669666.667-56%
Usd Book Value Change Per Share---1.277-1.2770%-2.828+121%0.474-370%0.474-370%
Usd Book Value Per Share--1.4211.4210%2.698-47%3.215-56%3.215-56%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.030-1.0300%-1.991+93%-1.394+35%-1.394+35%
Usd Free Cash Flow---9710000.000-9710000.0000%-10851000.000+12%-6853666.667-29%-6853666.667-29%
Usd Free Cash Flow Per Share---1.672-1.6720%-1.868+12%-1.598-4%-1.598-4%
Usd Free Cash Flow To Equity Per Share---1.050-1.0500%-1.878+79%-0.377-64%-0.377-64%
Usd Price Per Share0.000-623233%1.8701.8700%1.810+3%1.423+31%1.423+31%
Usd Profit---8417000.000-8417000.0000%-25707000.000+205%-20789000.000+147%-20789000.000+147%
Usd Revenue--2216000.0002216000.0000%19565000.000-89%13340333.333-83%13340333.333-83%
Usd Total Gains Per Share---1.277-1.2770%-2.828+121%0.474-370%0.474-370%
 EOD+3 -2MRQTTM+0 -0YOY+25 -145Y+16 -2310Y+16 -23

3.2. Fundamental Score

Let's check the fundamental score of Adynxx Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than0-3.798
Operating Margin (MRQ)Greater than0-2.310
Quick Ratio (MRQ)Greater than10.004
Current Ratio (MRQ)Greater than10.202
Debt to Asset Ratio (MRQ)Less than10.147
Debt to Equity Ratio (MRQ)Less than10.173
Return on Equity (MRQ)Greater than0.15-1.020
Return on Assets (MRQ)Greater than0.05-0.870
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Adynxx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5096.478
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2018-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets9,679
Total Liabilities1,427
Total Stockholder Equity8,252
 As reported
Total Liabilities 1,427
Total Stockholder Equity+ 8,252
Total Assets = 9,679

Assets

Total Assets9,679
Total Current Assets1,952
Long-term Assets1,952
Total Current Assets
Cash And Cash Equivalents 8,880
Net Receivables 34
Other Current Assets 55
Total Current Assets  (as reported)1,952
Total Current Assets  (calculated)8,969
+/- 7,017
Long-term Assets
Property Plant Equipment 10
Long-term Assets Other 178
Long-term Assets  (as reported)378
Long-term Assets  (calculated)188
+/- 190

Liabilities & Shareholders' Equity

Total Current Liabilities9,660
Long-term Liabilities51
Total Stockholder Equity8,252
Total Current Liabilities
Short-term Debt 3,812
Short Long Term Debt 3,812
Accounts payable 491
Other Current Liabilities 474
Total Current Liabilities  (as reported)9,660
Total Current Liabilities  (calculated)8,589
+/- 1,071
Long-term Liabilities
Long-term Liabilities Other 51
Long-term Liabilities  (as reported)51
Long-term Liabilities  (calculated)51
+/-0
Total Stockholder Equity
Common Stock20
Total Stockholder Equity (as reported)8,252
Total Stockholder Equity (calculated)20
+/- 8,232
Other
Capital Stock5
Common Stock Shares Outstanding 834
Net Invested Capital 8,252
Net Tangible Assets -36,531
Net Working Capital 7,925



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2018-12-312017-12-312016-12-31
> Total Assets 
54,499
32,941
9,679
9,67932,94154,499
   > Total Current Assets 
14,909
4,335
1,952
1,9524,33514,909
       Cash And Cash Equivalents 
5,580
2,181
8,880
8,8802,1815,580
       Net Receivables 
0
0
34
3400
       Inventory 
2,702
1,551
101
1011,5512,702
   > Long-term Assets 
42,722
25,464
378
37825,46442,722
       Property Plant Equipment 
20
13
10
101320
       Goodwill 
11,959
1,659
0
01,65911,959
       Intangible Assets 
28,498
22,069
0
022,06928,498
       Long-term Assets Other 
173
173
178
178173173
> Total Liabilities 
22,409
17,274
1,427
1,42717,27422,409
   > Total Current Liabilities 
1,305
3,572
9,660
9,6603,5721,305
       Short-term Debt 
11,541
10,929
3,812
3,81210,92911,541
       Short Long Term Debt 
11,541
10,929
3,812
3,81210,92911,541
       Accounts payable 
102
703
491
491703102
       Other Current Liabilities 
841
289
474
474289841
   > Long-term Liabilities 
2,275
304
51
513042,275
       Long-term Liabilities Other 
1,526
304
51
513041,526
> Total Stockholder Equity
32,090
15,667
8,252
8,25215,66732,090
   Common Stock
20
20
20
202020
   Retained Earnings Total Equity000
   Accumulated Other Comprehensive Income 000
   Capital Surplus 000
   Treasury Stock000
   Other Stockholders Equity 000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2018-12-31)

Gross Profit (+$)
totalRevenue2,216
Cost of Revenue-1,720
Gross Profit496496
 
Operating Income (+$)
Gross Profit496
Operating Expense-7,512
Operating Income-5,296-7,016
 
Operating Expense (+$)
Research Development1,014
Selling General Administrative5,750
Selling And Marketing Expenses-
Operating Expense7,5126,764
 
Net Interest Income (+$)
Interest Income24
Interest Expense-24
Net Interest Income240
 
Pretax Income (+$)
Operating Income-5,296
Net Interest Income24
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-7,004-3,564
EBIT - interestExpense = -5,143
-8,417
-8,393
Interest Expense24
Earnings Before Interest and Taxes (ebit)-5,119-6,980
Earnings Before Interest and Taxes (ebitda)-3,415
 
After tax Income (+$)
Income Before Tax-7,004
Tax Provision-0
Net Income From Continuing Ops-7,004-7,004
Net Income-8,417
Net Income Applicable To Common Shares-5,985
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,732-24
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ICICITECH.BSE
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ICICITECH.BSE.

ICICITECH.BSE Daily Candlestick Chart
HTMEDIA.NSE
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HTMEDIA.NSE.

HTMEDIA.NSE Daily Candlestick Chart
XLE.MX
28 minutes ago

I found you a Death Cross on the daily chart of XLE.MX.

XLE.MX Daily Candlestick Chart
VASCONI.MX
30 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of VASCONI.MX.

VASCONI.MX Daily Candlestick Chart
SPORTS.MX
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.MX.

SPORTS.MX Daily Candlestick Chart
LABB.MX
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LABB.MX.

LABB.MX Daily Candlestick Chart
ALFAA.MX
31 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ALFAA.MX.

ALFAA.MX Daily Candlestick Chart
PABW.MU
1 hour ago

I found you a Golden Cross on the daily chart of PABW.MU.

PABW.MU Daily Candlestick Chart
IS0E.F
1 hour ago

I found you a Evening Star Candle Pattern on the daily chart of IS0E.F.

IS0E.F Daily Candlestick Chart
EXH2.F
1 hour ago

I found you a Morning Star Candle Pattern on the daily chart of EXH2.F.

EXH2.F Daily Candlestick Chart
SDOS.ST
1 hour ago

I found you a Death Cross on the daily chart of SDOS.ST.

SDOS.ST Daily Candlestick Chart
M6X3.F
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of M6X3.F.

M6X3.F Daily Candlestick Chart
8CN.F
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 8CN.F.

8CN.F Daily Candlestick Chart
ELEC.PA
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ELEC.PA.

ELEC.PA Daily Candlestick Chart
9SU.F
2 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of 9SU.F.

9SU.F Daily Candlestick Chart
ZEON.F
2 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of ZEON.F.

ZEON.F Daily Candlestick Chart
WS0.F
2 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of WS0.F.

WS0.F Daily Candlestick Chart
TE9.F
2 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of TE9.F.

TE9.F Daily Candlestick Chart
3NFE.XETRA
2 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 3NFE.XETRA.

3NFE.XETRA Daily Candlestick Chart
CATG.PA
2 hours ago

I found you a Morning Star Candle Pattern on the daily chart of CATG.PA.

CATG.PA Daily Candlestick Chart
O3S1.F
2 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of O3S1.F.

O3S1.F Daily Candlestick Chart
ALPHA.PA
2 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of ALPHA.PA.

ALPHA.PA Daily Candlestick Chart
ALKKO.PA
2 hours ago

I found you a Golden Cross on the daily chart of ALKKO.PA.

ALKKO.PA Daily Candlestick Chart
ALHYG.PA
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ALHYG.PA.

ALHYG.PA Daily Candlestick Chart